Voyager Therapeutics, Inc. (VYGR) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 6.2% on average (either way), rising 4 times and falling 8. EPS beat estimates 9 of 12 times; revenue 6 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-05 | -0.40 | -0.42 | +4.5% | 4.0M | 6.3M | -0.3% |
| Q2 FY2026 | 2026-08-06 | -0.40 | -0.48 | +17.3% | 3.2M | 4.5M | +5.5% |
| Q1 FY2026 | 2026-05-07 | -0.47 | -0.54 | +13.0% | 2.6M | 8.8M | -2.9% |
| Q4 FY2025 | 2026-03-09 | -0.46 | -0.54 | +14.8% | 15.3M | 10.5M | +28.2% |
| Q3 FY2025 | 2025-11-10 | -0.47 | -0.53 | +11.3% | 13.4M | 10.5M | +0.7% |
| Q2 FY2025 | 2025-08-06 | -0.57 | -0.48 | -18.8% | 5.2M | 7.9M | -4.7% |
| Q1 FY2025 | 2025-05-06 | -0.53 | -0.35 | -51.4% | 6.5M | 13.9M | -6.0% |
| Q4 FY2024 | 2025-03-11 | -0.59 | -0.35 | -68.6% | 6.3M | 12.9M | -2.6% |